key: cord-0698705-vcfwsero
authors: Alquisiras-Burgos, Iván; Peralta-Arrieta, Irlanda; Alonso-Palomares, Luis Antonio; Zacapala-Gómez, Ana Elvira; Salmerón-Bárcenas, Eric Genaro; Aguilera, Penélope
title: Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection
date: 2020-09-25
journal: Mol Neurobiol
DOI: 10.1007/s12035-020-02134-7
sha: 2e6ec7d726161019d4a66a4fa2dcb01322dc9d9b
doc_id: 698705
cord_uid: vcfwsero

The main discussion above of the novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has focused substantially on the immediate risks and impact on the respiratory system; however, the effects induced to the central nervous system are currently unknown. Some authors have suggested that SARS-CoV-2 infection can dramatically affect brain function and exacerbate neurodegenerative diseases in patients, but the mechanisms have not been entirely described. In this review, we gather information from past and actual studies on coronaviruses that informed neurological dysfunction and brain damage. Then, we analyzed and described the possible mechanisms causative of brain injury after SARS-CoV-2 infection. We proposed that potential routes of SARS-CoV-2 neuro-invasion are determinant factors in the process. We considered that the hematogenous route of infection can directly affect the brain microvascular endothelium cells that integrate the blood-brain barrier and be fundamental in initiation of brain damage. Additionally, activation of the inflammatory response against the infection represents a critical step on injury induction of the brain tissue. Consequently, the virus’ ability to infect brain cells and induce the inflammatory response can promote or increase the risk to acquire central nervous system diseases. Here, we contribute to the understanding of the neurological conditions found in patients with SARS-CoV-2 infection and its association with the blood-brain barrier integrity.

Coronaviruses (CoVs) belong to the order Nidovirales and family Coronaviridae which is grouped on four genera based on phylogeny: Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and Deltacoronavirus (International Committee for Taxonomy of Virus; https://talk.ictvonline. org/). CoVs are envelopment and spherical particles of 80 to 120 nm in diameter with a crown-like structures. This family contains the largest and non-segmented RNA genome, which is formed with a single-strand positive-sense around 27 to 32 kb in size [1] . CoVs' genome shares structural organization, although differs in the base pairs number and sequence, even among closely related CoVs. The open reading frames 1a/b (ORF1a and ORF1b), located at the 5′ end encode nonstructural components, the polyproteins pp1a and pp1b. Two viral proteases cleave these proteins to generate 16 nonstructural proteins (nsp1 to nsp16), including the RNAdependent RNA polymerase (RdRP), an important protein Pathogenicity and transmission capacity of any pathogen are indicated from the R 0 value. Epidemiologically, R 0 is defined as the average number of people who will acquire a disease from an infected person. Therefore, R 0 indicates the potential spread (contagious) or decline of disease. When R o < 1, the condition will decline and eventually disappear; if R 0 = 1, the disease will stay alive, but will not turn in to an epidemic; with values of R o > 1, cases could grow exponentially and cause an epidemic or a pandemic [12] . The transmissibility and mortality rate of SARS-CoV-2 have been reported by several authors, and the estimated value is so far under debate (for more detail, see reference Liu et al. [12] ). However, according to Chen et al. [13] , it is estimated that SARS-CoV-2 has The SARS-CoV-2 genome size is around 32 kb and is an RNA single-strand positivesense that encodes 16 nonstructural proteins (5′ end) and 4 structural proteins (3′ end) (S, E, M, and N) and 6 accessory proteins. SARS-CoV-2 genome. The genome contains a PoliA tail at 3′ end relatively low pathogenicity (3%) and moderate transmissibility (R 0 = 1. 4-5.5) .

COVID-19 is the illness caused by SARS-CoV-2 infection. SARS-CoV-2 infects the higher upper respiratory tract, but with increased disease severity, the lower respiratory tract is also affected. The main routes of transmission are respiratory droplets and human-to-human, close contact [7, 14, 15] . However, oral-fecal transmission, tears secretion, aerosols, fomites, and even air and surface environmental (e.g., patient's room, floor, air outlet fan, toilet area, and personal protective equipment) are other possible routes of virus' transmission; nevertheless, the effectiveness of these alternative routes is still controversial [15] [16] [17] [18] . SARS-CoV-2 infection is possible for the entire population; however, the severity of the illness depends on some highlighted aspects seen around the world. In this sense, higher percentages of infection have been diagnosed in men than in women [19] [20] [21] , and elderly males (≥ 80 years) are the group more susceptible to complications [22] . Besides, chronic underlying diseases, such as hypertension, diabetes, coronary heart disease, and cancer, have a meaningful impact in case fatality risk [22, 23] . On the other hand, pediatric patients (2 months to 17 years) may have mild symptoms or be asymptomatic; in fact, they have their own clinical features [24] [25] [26] [27] .

The period of incubation of the SARS-CoV-2, which determines the time in which symptoms are observed, has a wide range from 1 to 14 days [14, 20, 28] . Early and common symptoms by COVID-19 include fever, dry cough, shortness of breath, and chest pain; other symptoms include myalgia, fatigue, and headache. Less common symptoms are sputum production, hemoptysis, and gastrointestinal symptoms, including diarrhea, nausea, and vomiting [22, [28] [29] [30] [31] . Depending on illness evolution, COVID-19 might be classified according to the severity of the clinical symptoms in mild (i.e., non-pneumonia and development mild pneumonia); severe (i.e., dyspnea, respiratory frequency ≥ 30 breaths per minute, blood oxygen saturation ≤ 93%, the partial pressure of arterial oxygen to fraction of inspired oxygen ratio < 300, and lung infiltrates > 50% in the first 24 to 48 h); and critical (i.e., respiratory failure, sepsis, septic shock, acute respiratory distress syndrome, and/or multiple organ dysfunction or failure, for example, heat failure, coagulopathy, acute cardiac, and acute kidney injury) [22, 23, 31] .

Clinical diagnosis is made based on symptoms, exposure, and chest imaging that show the presence of lung imaging features consistent with CoVs pneumonia that includes ground-glass lung [32, 33] . The respiratory tract is the classical target for SARS-CoV-2 infection; nonetheless, the virus is also visualized by immunofluorescent staining in gastric, duodenal, and rectum glandular epithelial cells [18] , showing other target tissues and complexity of the illness. Interestingly, there is evidence of signs and symptoms of COVID-19 patients (Table 1 ) and other HCoVs infections [38] .

Up to date, many reports have described the association between respiratory viral infections with neurological symptoms. There are several recognized respiratory pathogens that gain access to the central nervous system (CNS), for instance, respiratory syncytial virus, the influenza virus, the human metapneumovirus, and HCoVs (HCoV229E, HCoV-OC43, and SARS-CoV) [39] , that induce manifestations such as febrile or afebrile seizures, among other encephalopathies [40, 41] .

Primary cultures of human astrocytes and microglia and various human neuronal cell lines, such as the neuroblastoma SK-N-SH, the neuroglioma H4, and the oligodendrocytic MO3.13, have potential tropism for HCoV-OC43 [42] .

Using an experimental animal model, HCoV-OC-43 infection also showed neuro-invasiveness and neuro-virulence [43] . Therefore, it is not surprising to find brain SARS-positive autopsies. Using in situ hybridization, the SARS genomic sequence has been detected in the cytoplasm of neurons of the hypothalamus and cerebral cortex [44] . Furthermore, Moriguchi et al. [45] confirmed the presence of the new SARS-CoV-2 in cerebral spinal fluid. In accord, epidemiological and clinical research have described neurological, noncommon symptoms, and neurological manifestations associated with the SARS-CoV-2 infection (Table 2 ). These clinical features include neuralgia, confusion, hyposmia, hypogeusia, and altered consciousness, symptoms that evidence the neurotropic invasion by SARS-CoV-2 [19, 41] .

Despite the evidence demonstrating the neurotropism of respiratory viruses, the exact mechanism of neuro-invasion accomplished by viruses remains currently unknown. However, the route of invasion of the CNS has recently been described for HCoV-OC-43. This virus gains access to the CNS through the olfactory bulb, moving along the olfactory nerve. Then, neuro-propagation occurs along the multiple axonal connections expanding through the CNS (e.g., neuron-toneuron propagation or diffusing particles) [56] . Similar to HCoV-OC-43, a model in vivo of SARS-CoV infection suggested that the virus enters the brain via the olfactory bulb, and then, a transneuronal spread could occurs [57] .

Also, some infectious blood-borne viruses primarily targeting peripheral organs have evolved strategies to thwart the blood-brain barrier (BBB). These strategies include direct infection of the brain microvascular endothelial cells that form the BBB, a paracellular entry that involves alteration of the tight junctions, or the "Trojan horse" invasion, via the traffic of infected monocytes/macrophages migrating across the BBB, in a similar manner as the not-respiratory immunodeficiency virus 1 (HIV-1) [58, 59] . Likewise, when human primary monocytes are activated following infection by HCoV-229E and eventually become macrophages, it can invade tissues, including the CNS [60, 61] . Additionally, it has been reported that through activation of the brain microendothelium, the damage caused by the inflammatory response, allows the virus to reach the CNS. In this sense, the neuro-invasion of SARS-CoV-2 could occur through trans-synaptic transfer, via the olfactory nerve, infection of vascular endothelium, or leukocyte migration across the BBB [38] .

The cellular tropism of CoV depends on the location of its receptor which can be expressed in cells different from those of the respiratory system. Therefore, if SARS-CoV-2 has Case report n = 1 patient Anosmia [35] Retrospective observational study n = 114 patient Anosmia associated with dysgeusia 54 (47%) [36] Retrospective report n = 24 males n = 19 females CNS syndromes Encephalopathies 10 (23%) Symptoms: confusion and disorientation, psychosis, and seizures Neuroinflammatory syndromes 12 (27%) Symptoms: encephalitis, features of an autoimmune encephalitis stimulus sensitive myoclonus, and convergence spasm. Confusion and seizure. Acute demyelinating encephalomyelitis (ADEM): 9 (21%) Hemorrhagic 5 (12%) Necrotizing encephalitis 1(2%), Myelitis 2(5%) Hemorrhagic leucoencephalitis 1(2%) [37] reached the CNS, the infection of brain cells depends on receptor recognition. It is the first step of viral infection and a key determinant of the host cell and tissue tropism. Walls et al. [62] reported that the angiotensin-converting enzyme 2 (ACE2), a metallopeptidase, mediates SARS-CoV-2 entry into cells, establishing it as a functional receptor for this recently appeared CoV. Previous studies achieved with SARS-CoV also showed that the binding affinity between viruses and human ACE2 correlates with increased virus transmissibility and disease severity in humans [63] .

The human ACE2 protein is included within the renin angiotensin system (RAS) which is widely known for its physiological roles in electrolyte homeostasis, body fluid volume regulation, and cardiovascular control in the peripheral circulation. Renin, an enzyme produced from the kidney, acts on angiotensinogen (AGT), a liver precursor, to release angiotensin I (Ang I), an inactive decapeptide. Human ACE2 cleaves Ang I to convert it to the active octapeptide Ang II, the effector peptide of RAS, which is essential for various physiological functions [64] .

The RAS has been described in various tissues such as the heart, the kidney, the lungs, the liver, the retina, and the brain [64, 65] . Chen et al. [66] screened the human ACE2 mRNA expression in human organs based on hGTEx database. They found that the digestive tract intestine displayed the highest expression of human ACE2, followed by the testis and the kidney. Consequently, the high vulnerability to SARS-CoV-2 to these organs could explain the positive detection of the virus in the patient's feces and urine [67] . The expression of human ACE2 in the heart is lower than that in the intestine and Case report n = 1 patient 65 Y/A male Guillain-Barré syndrome Acute progressive symmetric ascending quadriparesis, facial paresis bilaterally Oropharyngeal specimen [52] Case report n = 5 patients Guillain-Barré syndrome Nasopharyngeal specimen [53] Case report n = 1 patient Guillain-Barré syndrome Nasopharyngeal specimen [54] Case report n = 1 patient 58 Y/A female Acute hemorrhagic necrotizing encephalopathy Altered mental status Nasopharyngeal specimen [55] kidney but higher than that in the lung, which serves as the main target organ for SARS-CoV-2, indicating a potential infection susceptibility of the human heart.

Unfortunately, there is relatively little information available on both the expression and regulation of RAS in the brain [68, 69] . Dzau et al. [70] demonstrated the expression of the ACE2 mRNA in mouse and rat brains using Northern blot analyses, although low levels of the human ACE2 mRNA were shown in the human brain using quantitative real-time RT-PCR [71, 72] . Chappell et al. [73] made the first demonstration of the endogenous presence of the ACE2 protein in brain tissues of rats using reverse-phase high-performance liquid chromatography and radioimmunoassays. Later, immunohistochemistry studies showed that human ACE2 protein was restricted to endothelial and arterial smooth muscle cells of cerebral vessels [74] . However, Lavoie et al. [68] produced double-transgenic mice which express the green fluorescent protein driven by the renin promoter and the β-galactosidase driven by the human angiotensin gene promoter and found that both proteins are co-expressed in the medulla, the pons, the amygdala, the hypothalamus, and the hippocampus; additionally, other regions only expressed the ACE2 protein.

Interestingly, ACE2 protein is predominant but not exclusive of neurons; astrocytes and glial cells also express it [68, 75, 76] . Additionally, it is possible that the brain endothelium expresses the ACE2 protein since recent studies demonstrated the susceptibility to the infection of endothelial cells in other tissues [66, 77] .

The virus surface-anchored spike protein (S) mediates the SARS-CoV-2 entry to the target cell. Protein S contains a receptor-binging domain (RBD) that specifically recognizes the ACE2. The RBD shows a hidden position in SARS-CoV-2 that lead to poor recognition of the host receptor; however, this problem is overcome with an ACE2 high binding affinity and a furin motif that allows its spike to be pre-activated. Therefore, pro-protein convertase furin (PCF) plays an essential role in virus' membrane fusion [78, 79] . PCF is a ubiquitously expressed subtilisin-related serine protease and member of the pro-protein convertase family that functions within the secretory and endocytic pathways and at the cell surface, cleaving pro-proteins. PCF has several substrates that include growth factors, receptors, coagulation proteins, plasma proteins, extracellular matrix components, and protease precursors (e.g., matrix metalloproteases). PCF activity contributes to numerous functions in CNS and also is involved in chronic pathological conditions [80] . PCF cleavage of viral envelope glycoproteins is necessary for the propagation of many lipid-enveloped viral pathogens. Accordingly, sequence alignment indicates that the PCF cleavage site in S protein is essential in CoV evolution [81] . Notably, the PCF cleavage site is involved in pathogenicity and modulates neuro-virulence. Some mutations in PCF induce severe encephalitis and break the BBB [82] , while others lead to reduced neurotropism and limited dissemination within the CNS [83] . Therefore, evidence supports that SARS-CoV-2 can reach SNC and infect brain cells through S protein binding to ACE2 and modification by PCF.

The microvascular endothelial cells that form the BBB protect the CNS from a wide variety of toxins and microorganisms found in the blood. These cells express tight junction proteins that limit the movement between adjacent cells and are through specific transporters and receptor proteins that control entry and exit of molecules coming from the blood toward the brain parenchyma [84] . Therefore, the study of the damage induced to microvascular endothelial cells represents the central framework for understanding the molecular mechanisms of virus infection in the CNS [85, 86] .

Disruption of the BBB occurs upon infection with several recognized neurotropic viruses. Arbovirus that belongs to the Flaviviridae family, such as the West Nile Virus and the Zika virus, can induce damage in the BBB caused by the host cell's response to viral factors. Experiments carried out using in vitro and in vivo models of the BBB have demonstrated that these viruses replicate in the brain microvascular endothelial cells and induce down-regulation and degradation of tight junction proteins leading to disruption of the BBB [87] [88] [89] [90] . Similarly, Bleau et al. [91] evaluated the ability of CoV to enter the CNS, using the highly hepatotropic mouse hepatitis virus type 3 and the weakly hepatotropic mouse hepatitis type A59. The type 3-infected mice showed brain invasion that correlated with enhanced BBB permeability. The effect was associated with decreased expression of the zona occludens protein 1, the VE-cadherin, and the occludin. Since CoV are molecularly related in its mode of replication, it is speculated that other types of CoV use a similar mechanism of action to infect the brain microvascular endothelial cells [92, 93] . Importantly, it has been identified the presence of SARS-CoV-2 in the brain microvascular endothelial cells in frontal lobe tissue obtained at postmortem examination from a patient with COVID-19 [94] . Besides, viral particles and viral genome sequences of SARS-CoV have been detected in the cytoplasm of neurons of the brain, mainly in the hypothalamus and the cortex [44, 95] . This evidence suggests that SARS-CoV-2 crosses the BBB as well as others HCoV. Therefore, infection by several respiratory viruses, including SARS-CoV-2, affects the integrity of the BBB through different mechanisms. The virus causes direct cell stress, associated with most of the cytotoxic effects that lead to degeneration of infected cells, for example, SARS-CoV induces apoptosis [96] . Endothelial cells activation as part of the inflammatory response causes an increase in the expression of proteases, such as matrix metalloproteinase, that promotes the degradation of the tight junction proteins [97] . However, it is probable that the inflammatory response plays the most important role in the induction of the damage to BBB.

The regular activity of neuroinflammation is mainly to restore the homeostasis in the brain [98] . However, prolonged CNS inflammation and systemic inflammatory response as a result of a wide variety of pathologies such as viral infections may influence the BBB integrity and further outcome in neurological disorders [99, 100] . Therefore, SARS-CoV-2 could cause damage to the BBB through the activation of the inflammatory immune response associated with a dysregulation around this process [101] .

Activation of the microvascular endothelial cells has been associated with changes in BBB permeability. For example, during physiological conditions, immune cell migration into the CNS is rigorously controlled by mechanisms that operate at the level of the BBB. Notably, migration of circulating immune cells into the CNS is low and restricted to specific innate and adaptative immune cell subsets, such as lymphocytes, macrophages, and antigen presenting cells as dendritic cells that maintain immune surveillance in the CNS [102] . However, during viral infections, the migration of immune cells is increased. This is supported by histopathologic examination of the brain tissue in patients with SARS-CoV, where pathological infiltration of CD68 + monocytes/macrophages and CD3 + T lymphocytes has been found in the brain mesenchyme [95] . Similarly, the infiltration process, related to interactions between the β1 and β2 integrins expressed on leukocytes and their ligands [i.e., intercellular adhesion molecules (ICAM): ICAM-1, ICAM-2, and vascular cell adhesion molecule-1 (VCAM-1)] present on the surface of the microendothelial cells, that induce extravasation across the BBB under inflammatory conditions has been reported [103] [104] [105] [106] [107] . Evidence suggests that infection and activation of the microvascular endothelial cells by typical neurotrophic viruses increased endothelial adhesion molecules expression [88] . This condition facilitates the trafficking of virusesinfected immune cells into the CNS via the 'Trojan horse' mechanism [88] .

Likewise, during viral replication in the host cells, the damage is caused because SARS-CoV-2 is a cytopathic virus that induces the release of damage-associated molecular patterns (DAMPs) [108] . DAMPs are endogenous molecules released from damaged cells that interact with molecules called pattern-recognition receptor (PRR) that induce in the neighboring epithelial cells, endothelial cells, and macrophages a state of high inflammation [109] .

Once the virus interacts with the host cells, the viral genome and viral proteins can also be recognized by PRRs and activated the immune response. Different PRRs recognize SARS-CoV-2, for example, the Toll-like receptors (TLR), which are molecules expressed in many cell lines, including endothelial cells, macrophages, and dendritic cells. TLR3, TLR7, TLR8, and TLR9 induce several pathways of activation that produce proinflammatory cytokines and other antiviral molecules to control the infection. However, this response can be dysregulated and exacerbated cytokines production [110] . Also, NOD-like receptor (NLR), other PRR, activates the inflammasome complex and induces the activation state in some cell types such as macrophages and epithelial and even in the microvascular endothelial cells leading to high production of interleukin (IL)-1β and IL-18. Nevertheless, this mechanism needs to be studied in detail for the new CoV [111] .

On the other hand, the viral RNA activates typical molecules such as the retinoic acid inducible gene 1 and the melanoma differentiation associated gene 5 and induces an antiviral state, in which interferons (IFN) are secreted (mainly IFN type I and III). Interferons are molecules important to clearance the viral infection to prevent viruses from replicating [112, 113] . In patients with COVID-19, high levels of IFN, especially IFN I, are detected; this molecule blocks the viral replication in adjacent cells and produces some effects against the viral infection such as the induction of interferonstimulated gene expression, the stimulation of cytokines production, and the activation of immune response cells (i.e., macrophages, monocytes, and neutrophils) [112, 114] . Other CoV infections have a similar response [115, 116] .

Furthermore, patients infected with SARS-CoV-2 have increased levels of several cytokines and chemokines: TNF-α, IFN-γ, interleukin-1 receptor antagonist (IL-1RA), IL-2, IL-6, IL-7, IL-8, IL-9, IL-10, and the granulocyte macrophage colony-stimulating factor; importantly, high levels of IL-6 have been linked to a worse prognosis in COVID-19 patients [116, 117] . This high production and misbalance of all these molecules is defined as cytokines storm (CS), which could be an essential factor to cause disruption of the BBB [110] . Interestingly, CS induces the activation of platelets, neutrophils, monocytes, and macrophages; additionally, some of these molecules can interact with the complement and the coagulation systems and contribute to the pathogenic inflammation [117] .

Furthermore, some chemokines can attract some innate immune response cells such as monocytes, natural killer cells, dendritic cells, and T cells [118] and induce the production others cytokines such as the monocyte chemotactic protein-1, the granulocyte colony-stimulating factor, the macrophages inflammatory protein 1-α, and IL-10 that recruit lymphocytes and monocytes and initiate the humoral response. Together, all these mechanisms can contribute to the severity of neurological symptoms of SARS-CoV-2 infection in the BBB [30] .

Other physiological disturbances in COVID-19 patients such as thrombocytopenia, lymphopenia (CD8 + T, CD4 + T, Treg cells, and platelets), and eosinopenia have also been describing. Blood samples and spleen and lymph nodes present these types of dysregulation due to the recruited cells to the infected sites to control the viral replication (Table 3 ) [119, 120] . Also, several patients present high levels of D-dimer in the early stage of the infection (Table 3) . This molecule is an important marker in the disorder of coagulation. It represents a thrombotic state that leads to embolic vascular events and can produce venous clots and induce brain damage [121] . Therefore, COVID-19 patients with high inflammation trigger excessive thrombin production that inhibits fibrinolysis and activates the complement pathways leading thromboinflammation, microthrombin deposition, and microvascular dysfunction associated with damage of the BBB [122, 123] .

An unexplored mechanism that could produce damage in the BBB is the adaptative immune response. The generation of antibodies (Abs) against SARS-CoV-2 can cross-react with some molecules of the brain microvascular endothelial cells and produce damage through the activation of the complement system (C3 and C4 proteins). Also, Ab-dependent enhancement phenomenon can increase the infection and contribute to the injury. This process has been extensively studied in Dengue and Zika virus infection, where the Abs produced in the first exposure can cross-react in a second exposure and enhance the infection instead of neutralizing it [124, 125] . Additionally, the Abs can generate an autoimmune attack and interact with the virus forming immune complexes and induce the complement system activation [126] .

Recently, some studies showed that the cellular immune response could be central to determine the disease condition.

Several viruses, including SARS-CoV-2, can activate CD4 + and CD8 + and induce clonal expansion, specific cell effectors, and cellular memory [127, 128] . Also, T cells can cross-react inducing a state of protection observed in unexposed people with SARS-CoV-2 [129, 130] . Finally, more studies around the interaction with SARS-CoV-2 and the host immune system need to be clarified. Research around the mechanisms involved in inflammation response can allow the development of strategies that might help to mitigate the health consequence of this pandemic.

As previously discussed, multiple respiratory viruses can affect the CNS. For example, the mouse hepatitis virus induces inflammation, BBB damage, and demyelination in rat models [131] . Likewise, a case report of HCoV-OC43 detected in nasopharyngeal and cerebral spinal fluid samples from a child patient exhibited acute disseminated encephalomyelitis, a low-prevalence CNS disease that induces demyelination [132] . The H1N1 virus, the causative agent of high mortality rates, also presented neurological complications. A retrospective study of the clinical files of 55 patients infected with H1N1 detected 50% of visible neurological symptoms [133] . Interestingly, most patients with neurological manifestations due to H1N1 infection manifested brain edema [134] . Importantly, in autopsy studies, patients with SARS-CoV showed endothelial activation associated with the loss of cerebral vascular integrity displaying multifocal hemorrhage [135] . Histological examination of brain tissue specimens of patients with SARS-CoV infection also showed neuronal degeneration, necrosis, edema, extensive glial cell hyperplasia, and cellular infiltration of the vascular walls by monocytes and lymphocytes [40] . With this background, several studies have attempted to characterize the neurological manifestations of SARS-CoV-2. An increasing number of individual case reports have emerged describing acute neurological disorders ranging from Guillain-Barré syndrome and acute myelitis to acute hemorrhagic necrotizing encephalopathy [136] . Although the long-term neurological implications of SARS-CoV-2 infection are still unknown, important clues suggest that complications of the disease are related to CNS invasion by damaging the BBB.

There is a very complex interaction between the brain cells and the cerebral vasculature. Consequently, preservation of the cerebrovascular function and its integrity has a central role in this sophisticated communication. Additionally, any derangements can have deleterious acute and chronic consequences such as the development of neurodegenerative diseases and dementia [137] .

Infectious agents have been suspected as contributing factors to dementia, especially in Alzheimer's disease (AD). Interestingly, the BBB disruption appears to be an early feature of this disease [138] . For instance, Bell et al. [139] demonstrated that BBB breakdown was derived in neurotoxic proteins infiltration (e.g., amyloid-β peptides, the hallmark of AD), affecting neurons and either initiating or exacerbating neurodegeneration. Also, Ueno et al. [140] using experimental animal models exhibiting some phenotypes of vascular dementia showed that BBB damage might be related to amyloid-β peptides accumulation. Accordingly, damage induced to the BBB by infectious agents might trigger neurodegenerative diseases in predisposed patients [141] . Therefore, viral infections such as SARS-CoV-2 could be associated with an increased risk of AD development and a faster rate of cognitive decline in older populations.

AD in systemic virus infection is an example of a condition that is primarily neurodegenerative; however, in many cases, it is not clear whether BBB changes are the cause or the effect of a neuropathology. Furthermore, it is possible that the BBB anomalies and the disease drive each other in a selfperpetuating manner, contributing to damage progression [142] . As mentioned, acute and chronic systemic inflammation accelerates the progress of AD [143] . Also, a 5-year follow-up study showed that viral infections, like the induced by cytomegalovirus, are linked with faster cognitive decline and development of AD [144] . Furthermore, systemic inflammation in AD is associated with several BBB changes, which further favor amyloid-β peptides accumulation into the brain because the injury alters the influx and efflux of the peptides [145] ; correspondingly, systemic inflammation accelerates hippocampal amyloid-β peptides deposition [146] . Therefore, dysfunction of the BBB might play a significant role in the pathogenesis of vascular dementia induced by SARS-CoV-2 infection, but further observations are needed.

Additionally, damage to the BBB is not the only mechanism where SARS-CoV-2 infection can result in dementia. Some data suggest that amyloid-β protein possesses antimicrobial and antiviral activity in vitro [147] . Therefore, the presence of insoluble deposits of amyloid-β peptides could be a factor (e.g., genetic predisposing) that alter the response to viral SARS-CoV-2 infection. Thus, it is conceivable that SARS-CoV-2 contributes to BBB damage and also creates a feed-forward effect whereby pathogen-induced damage favors a further spread of the pathogen's transit zones and even the sequential development of the pathology associated to AD [138] .

On the other hand, individuals with AD are more vulnerable to the effects of peripheral infection, especially SARS-CoV-2, mainly due to the association of physical comorbidities. It is more probable that these individuals have cardiovascular disease, diabetes, and pneumonia [148] . Besides, there is an overall decrease in naive T cell diversity after the age of 65 [149] [150] [151] ; this can limit the capacity of the individual to induce a sufficient immune response to infection. Together, these data indicate the vulnerability of these patients to infection.

Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS, characterized by several pathological processes, including inflammation, trans-endothelial migration, demyelination, axonopathy, and neuron loss mediated by immune cells [152] . MS represents a neurological disease where an infectious agent plays a triggering role, being viruses the most likely culprit in genetically predisposed individuals [141] . There is a presumption that several neurotropic viruses using similar mechanisms could be involved in MS pathogenesis [153] . Some viruses that have been implicated in the development of MS include herpes viruses, paramyxoviruses, picornaviruses, as well as viruses that classically affect the respiratory system such as influenza virus [154] .

A critical step in the pathogenesis of MS is the infiltration of autoreactive CD4 + T-lymphocytes into the CNS after activation in the periphery. Evaluation of proinflammatory cytokines (IL-1β, IL-6, and IL-8), Th1 cytokines (IFN-γ, TNF-α, IL-2, and IL-12), and Th2 cytokines (IL-4, IL-5, and IL-10) in sera collected from SARS patients within 2 days of hospital admission showed a substantial elevation of IL-12, IL-6, IL-8, IL-10, and IFN-γ [155] . Also, Sonar et al. [156] revealed that IFN-γ favored the trans-endothelial migration of CD4 + T cells from the apical (luminal side) to the basal side (abluminal side) of the endothelial monolayer (Fig. 2) . Besides, using multicolor immunofluorescence and confocal microscopic analysis, these authors indicated that IFN-γ induce relocalization of ICAM-1, platelet endothelial cell adhesion molecule-1, zona occludens protein 1, and VE-cadherin in the endothelial cells. These findings reveal that the IFN-γ produced during the response to infection and inflammation could contribute to the disruption of the BBB and promote CD4 + T cells brain migration. Interestingly, BBB disruption appears in experimental autoimmune encephalomyelitis, a typical MS model, and the clinical severity is linked to the degree of BBB integrity [157] . Furthermore, imaging studies showed BBB disruption in normal-appearing white matter in MS [158] . This data is important since BBB breakdown precedes the development of new MS lesions [159] . In summary, it is possible that the damage caused by SARS-CoV-2 infection to the endothelial cells also causes loss of the BBB integrity, favoring MS progression.

Recent information has shown the SARS-CoV-2 ability to infect CNS cells, especially the brain microvascular endothelial cells of the BBB. This situation explains the neurological symptoms observed during infection and reveals the possible consequences of viral infection. Although it is too early to elucidate the long-term side effects of SARS-CoV-2 infection, the background obtained with other respiratory viruses suggests that SARS-CoV-2 might induce permanent sequelae in the CNS through damage to the BBB, including dementia in predisposed patients. Furthermore, the proinflammatory state, due to viral infection seems to be the general mechanism involved in the induction of BBB damage. However, further studies are necessary to confirm this evidence. Fig. 2 Possible mechanism of damage to the blood-brain barrier (BBB) by the action of SARS-CoV-2. a Expression of angiotensin-converting enzyme 2 (ACE2) and the pro-protein convertase furin (PCF) in the membrane of the brain microvascular endothelial cells facilitates SARS-CoV-2 infection. b SARS-CoV2 infection activates the brain microendothelial cells inducing high expression of the vascular and the intercellular adhesion molecules (VCAM and ICAM). Likewise, SARS-CoV-2 induces the expression and activation matrix metalloproteinases (MMP) that degrade tight junctions proteins. c Recognition of ICAM and ICAM through the β1 and β2 integrins causes binding of circulating leukocytes to endothelial cells that lead transcellular extravasation. This process facilitate viral entrance to the cerebral parenchyma through the "Trojan horse" mechanism. d SARS-CoV-2 viral replication induces endothelial cell contraction and lysis. Increased permeability of the BBB allows extravasation of plasma proteins and blood cells. Activation of leukocytes and platelets contributes to the BBB damage. Besides, endothelial cell death disturbs the microenvironment of the brain parenchyma allowing free passage of the SARS-CoV-2 virus and infection of other cells of the central nervous system

Origin and evolution of pathogenic coronaviruses

Molecular evolution of human coronavirus genomes

Epidemiology, genetic recombination, and pathogenesis of coronaviruses

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

A new coronavirus associated with human respiratory disease in China

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China

Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins

Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak

The reproductive number of COVID-19 is higher compared to SARS coronavirus

Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses

Community transmission of severe acute respiratory syndrome coronavirus 2

Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient

Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1

Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection

Evidence for gastrointestinal infection of SARS-CoV-2

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

New coronavirus: new challenges for pediatricians

Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus

Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study

Novel coronavirus infection in hospitalized infants under 1 year of age in China

Clinical characteristics of Covid-19 in New York City

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical features and treatment of COVID-19 patients in Northeast Chongqing

A diagnostic model for coronavirus disease 2019 (COVID-19) based on radiological semantic and clinical features: A multicenter study

Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single-center study in Shanghai, China

Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China

Sudden and complete olfactory loss of function as a possible symptom of COVID-19

Features of anosmia in COVID-19

The emerging spectrum of COVID-19 neurology: Clinical, radiological and laboratory findings

Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: A review

Neurologic alterations due to respiratory virus infections

The clinical pathology of severe acute respiratory syndrome (SARS): A report from China

Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review

Acute and persistent infection of human neural cell lines by human coronavirus OC43

Vacuolating encephalitis in mice infected by human coronavirus OC43

Multiple organ infection and the pathogenesis of SARS

A first case of meningitis/ encephalitis associated with SARS-coronavirus-2

COVID-19 presenting as stroke

Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke

Large-vessel stroke as a presenting feature of Covid-19 in the young

Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in downtown Los Angeles

Miller fisher syndrome and polyneuritis cranialis in COVID-19

Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence?

Guillain Barre syndrome associated with COVID-19 infection: a case report

Guillain-Barré syndrome associated with SARS-CoV-2

Guillain-Barré syndrome associated with SARS-CoV-2 infection

COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features

Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43

Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2

Viral disruption of the blood-brain barrier

Pathogenesis of human immunodeficiency virus-induced neurological disease

Activation of human monocytes after infection by human coronavirus 229E

Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain

Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

Receptor and viral determinants of SARScoronavirus adaptation to human ACE2

Role of brain renin angiotensin system in neurodegeneration: An update

Mitochondrial-dependent mechanisms are involved in angiotensin II-induced apoptosis in dopaminergic neurons

The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain

Detection of SARS-CoV-2 in different types of clinical specimens

Adjacent expression of renin and angiotensinogen in the rostral ventrolateral medulla using a dual-reporter transgenic model

Astrocytes synthesize angiotensinogen in brain

Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains

Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents

Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme

Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Renin angiotensin system in cognitive function and dementia

Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor-and angiotensin II receptor blocker-based cardiovascular therapies

Böttcher-Friebertshäuser E (2020) TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets

Structural basis of receptor recognition by SARS-CoV-2

Furin at the cutting edge: from protein traffic to embryogenesis and disease

Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site

The S2 subunit of QX-type infectious bronchitis coronavirus spike protein is an essential determinant of Neurotropism

Cleavage of a neuroinvasive human respiratory virus spike glycoprotein by proprotein convertases modulates neurovirulence and virus spread within the central nervous system

The dynamic blood-brain barrier

Beyond NMDA and AMPA glutamate receptors: Emerging mechanisms for ionic imbalance and cell death in stroke

Chapter four -blood-brain barrier Na transporters in ischemic stroke

The mechanism of the Zika virus crossing the placental barrier and the blood-brain barrier

West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier

Selective disruption of the blood-brain barrier by Zika virus

Type III interferons in antiviral defenses at barrier surfaces

Brain invasion by mouse hepatitis virus depends on impairment of tight junctions and beta interferon production in brain microvascular endothelial cells

Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans

Pathogenetic mechanisms of severe acute respiratory syndrome

Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Detection of severe acute respiratory syndrome coronavirus in the brain: Potential role of the chemokine mig in pathogenesis

Human coronaviruses: Viral and cellular factors involved in neuroinvasiveness and neuropathogenesis

Mechanism of West Nile virus neuroinvasion: a critical appraisal

Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity

Factors controlling permeability of the blood-brain barrier

Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier

Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19

Capture, crawl, cross: the T cell code to breach the blood-brain barriers

) β<sub>2</ sub> integrin-mediated crawling on endothelial ICAM-1 and ICAM-2 is a prerequisite for transcellular neutrophil diapedesis across the inflamed blood-brain barrier

Binding sites of leukocyte beta 2 integrins (LFA-1, mac-1) on the human ICAM-4/LW blood group protein

Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies

I domain of beta 2 integrin lymphocyte function-associated antigen-1 contains a binding site for ligand intercellular adhesion molecule-1

VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration

Virus isolation from the first patient with SARS-CoV-2 in Korea

SARScoronavirus replication in human peripheral monocytes/macrophages

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

SARS unique domain (SUD) of severe acute respiratory syndrome coronavirus induces NLRP3 Inflammasome-dependent CXCL10-mediated pulmonary inflammation

induced hemoglobin subunit beta may stimulate innate immune RNA virus pattern recognition, suppress reactive oxygen species, reduce ACE2 viral doorway opening, and neutrophil extracellular traps against COVID-19

Double-stranded RNA sensors and modulators in innate immunity

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

SARS-CoV and IFN: too little, too late

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

The pathogenesis and treatment of the`cytokine storm' in COVID-19

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China

SARS-CoV-2 infection does not significantly cause acute renal injury: an analysis of 116 hospitalized patients with COVID-19 in a single hospital

COVID-19 and its implications for thrombosis and anticoagulation

Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms

Endothelial cell infection and endotheliitis in COVID-19

Is COVID-19 receiving ADE from other coronaviruses?

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies

Fcgamma receptors as regulators of immune responses

Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals

Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Analysis of the intrathecal humoral immune response in Brown Norway (BN) rats, infected with the murine coronavirus JHM

Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis

The neurological manifestations of H1N1 influenza infection; diagnostic challenges and recommendations

Neurological complications of pandemic influenza (H1N1) in children

Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells

COVID-19, SARS and MERS: A neurological perspective

Brain vasculature and cognition

Genetic, transcriptome, proteomic, and epidemiological evidence for blood-brain barrier disruption and Polymicrobial brain invasion as determinant factors in Alzheimer's disease

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease

Blood-brain barrier damage in vascular dementia

Epidemiologic evidence for multiple sclerosis as an infection

The blood-brain barrier in systemic inflammation

Systemic inflammation and disease progression in Alzheimer disease

Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals

Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease

Peripheral administration of poly I:C leads to increased hippocampal amyloid-beta and cognitive deficits in a non-transgenic mouse

Protective effect of amyloid-β peptides against herpes simplex Virus-1 infection in a neuronal cell culture model

Anticipating and mitigating the impact of the COVID-19 pandemic on Alzheimer's disease and related dementias

Thymic aging and T-cell regeneration

Role of neuroinflammation in neurodegeneration: New insights

The influence of age on T cell generation and TCR diversity

Multiple sclerosis

Multiple sclerosis: autoimmunity and viruses

Viruses and multiple sclerosis

T cell responses to whole SARS coronavirus in humans

IFN-γ promotes transendothelial migration of CD4+ T cells across the blood-brain barrier

Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models

Accurate determination of bloodbrain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients

Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions

Related links International Committee on Taxonomy of Viruses

World Health Organization

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Acknowledgments We would like to thank the Consejo Nacional de Ciencia y Tecnología (CONACYT) for the scholarship No. 413994 assigned to Iván M. Alquisiras Burgos, doctoral student from Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México (UNAM). We also thank the postdoctoral fellowship program DGAPA-UNAM assigned to Irlanda Peralta Arrieta at FES-Iztacala, UBIMED, and postdoctoral fellowship N°SECTEI/138/2019 from Mexico City assigned to Luis Alonso Palomares.

Authors' Contributions All authors contributed substantially to research